Rafael Holdings CEO Conkling Steps Down; Replaced by Former CEO Jonas

Dow Jones

04-25

By Roshan Fernandez

Rafael Holdings said Chief Executive Bill Conkling will be stepping down from his role following the clinical and early-stage pharmaceutical company's merger with Cyclo Therapeutics.

Conkling's departure is effective May 31. Rafael's executive chairman and former CEO, Howard Jonas, will assume the role of CEO at the Newark, N.J.-based company, effective June 1.

Conkling, who has been CEO since 2022, helped identify opportunities with the potential to transform Rafael into a late-stage clinical biotechnology company. Rafael completed its merger with Cyclo on March 26.

Jonas, 68 years old, has served as chairman of the board since 2017. He was also previously CEO from March 2018 through April 2021.

Write to Roshan Fernandez at roshan.fernandez@wsj.com

(END) Dow Jones Newswires

April 24, 2025 17:33 ET (21:33 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2530399113"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2530399113\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2530399113?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-25 05:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2530399113","market":"hk","top_or_hot":-1,"title":"Rafael Holdings CEO Conkling Steps Down; Replaced by Former CEO Jonas","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Roshan Fernandez \n</p>\n<pre>\n \n</pre>\n<p>\n  Rafael Holdings said Chief Executive Bill Conkling will be stepping down from his role following the clinical and early-stage pharmaceutical company's merger with <a href=\"https://laohu8.com/S/CYTH\">Cyclo Therapeutics</a>. \n</p>\n<p>\n  Conkling's departure is effective May 31. Rafael's executive chairman and former CEO, Howard Jonas, will assume the role of CEO at the Newark, N.J.-based company, effective June 1. \n</p>\n<p>\n  Conkling, who has been CEO since 2022, helped identify opportunities with the potential to transform Rafael into a late-stage clinical biotechnology company. Rafael completed its merger with Cyclo on March 26. \n</p>\n<p>\n  Jonas, 68 years old, has served as chairman of the board since 2017. He was also previously CEO from March 2018 through April 2021. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Roshan Fernandez at roshan.fernandez@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 24, 2025 17:33 ET (21:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rafael Holdings CEO Conkling Steps Down; Replaced by Former CEO Jonas</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRafael Holdings CEO Conkling Steps Down; Replaced by Former CEO Jonas\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-25 05:33</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Roshan Fernandez \n</p>\n<pre>\n \n</pre>\n<p>\n  Rafael Holdings said Chief Executive Bill Conkling will be stepping down from his role following the clinical and early-stage pharmaceutical company's merger with <a href=\"https://laohu8.com/S/CYTH\">Cyclo Therapeutics</a>. \n</p>\n<p>\n  Conkling's departure is effective May 31. Rafael's executive chairman and former CEO, Howard Jonas, will assume the role of CEO at the Newark, N.J.-based company, effective June 1. \n</p>\n<p>\n  Conkling, who has been CEO since 2022, helped identify opportunities with the potential to transform Rafael into a late-stage clinical biotechnology company. Rafael completed its merger with Cyclo on March 26. \n</p>\n<p>\n  Jonas, 68 years old, has served as chairman of the board since 2017. He was also previously CEO from March 2018 through April 2021. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Roshan Fernandez at roshan.fernandez@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 24, 2025 17:33 ET (21:33 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RFL","symbol_name":"Rafael Holdings, Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2530399113","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2530399113","pubTimestamp":1745530380,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Rafael Holdings said Chief Executive Bill Conkling will be stepping down from his role following the clinical and early-stage pharmaceutical company's merger with Cyclo Therapeutics.Conkling's departure is effective May 31. Rafael's executive chairman and former CEO, Howard Jonas, will assume the role of CEO at the Newark, N.J.-based company, effective June 1.Conkling, who has been CEO since 2022, helped identify opportunities with the potential to transform Rafael into a late-stage clinical biotechnology company. Rafael completed its merger with Cyclo on March 26.Jonas, 68 years old, has served as chairman of the board since 2017. He was also previously CEO from March 2018 through April 2021.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"RFL":"Rafael Holdings, Inc."},"translate_title":"拉斐尔控股CEO康克林卸任；由前首席执行官乔纳斯接替","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RFL":0.9},"content_text":"By Roshan Fernandez \n\n\n \n\n\n  Rafael Holdings said Chief Executive Bill Conkling will be stepping down from his role following the clinical and early-stage pharmaceutical company's merger with Cyclo Therapeutics. \n\n\n  Conkling's departure is effective May 31. Rafael's executive chairman and former CEO, Howard Jonas, will assume the role of CEO at the Newark, N.J.-based company, effective June 1. \n\n\n  Conkling, who has been CEO since 2022, helped identify opportunities with the potential to transform Rafael into a late-stage clinical biotechnology company. Rafael completed its merger with Cyclo on March 26. \n\n\n  Jonas, 68 years old, has served as chairman of the board since 2017. He was also previously CEO from March 2018 through April 2021. \n\n\n \n\n\n  Write to Roshan Fernandez at roshan.fernandez@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 24, 2025 17:33 ET (21:33 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}